Neal K. Long Appointed as Chief Executive Officer at Cardiac Science Corporation
Published: Jun 20, 2012
Neal brings more than three decades of experience in the medical devices industry. Prior to this role, he was the CEO of Draeger Medical Systems' North American medical devices business and concurrently served as President of its global patient monitoring and IT businesses. Before joining Draeger, he was the Director of Philips' Chronic Care, New Clinical Ventures and General Manager of its Diagnostic ECG business unit. Neal has also worked for GE Marquette Medical Systems in Milwaukee, Wis., as Business Unit Manager for its Non-Invasive Cardiology unit and was Director of Marketing of its Cardiology Division.
"We are fortunate to have someone of Neal Long's caliber and experience step up to lead Cardiac Science," said Thomas Dietiker, Director, OEM and M&A, Opto Circuits (India) Ltd. He also added that, "With his 30-plus year career and renewed leadership, we hope to successfully implement our strategy and take advantage of the market opportunities ahead. His proven growth record has been propelled by a comprehensive knowledge of our business and products."
"I've devoted my career toward working for leaders such as Cardiac Science," Neal said. "Throughout my career, I've been committed to growth through knowledge, innovation, commitment and teamwork. Cardiac Science has excellent products, a great team and a great future, and combined with Opto Circuits' commitment to the cardiovascular business, I'm confident we will advance our competitive position in the marketplace."
A native of Iowa, Neal and his family have lived and worked in the Chicago, Milwaukee and Boston metropolitan areas. He is a long-time supporter of the International Society for Computerized Electrocardiology (ISCE) and served as a Director and Trustee. Neal joined Cardiac Science on May 31, and is headquartered in Waukesha, Wis.
About Cardiac Science
Cardiac Science, a wholly owned subsidiary of Opto Circuits (India) Ltd., develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, PC-based diagnostic workstations, Holter monitoring systems, hospital defibrillators, vital signs monitors, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick®, HeartCentrix®, Powerheart®, and Quinton® brands, is headquartered in Bothell, Washington. With customers in almost 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.
For updates and information on worldwide defibrillation and cardiac monitoring, find us on Facebook at http://facebook.com/cardiacscience, the Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, and YouTube at http://budurl.com/CSonYT
For media inquiries, contact:
For investor inquiries, contact:
Access our company logo: http://www.cardiacscience.com/images/main_logo.gif
SOURCE Cardiac Science Corporation